(NasdaqGM:AVDL), DUBLIN, Ireland, Jan. 22, 2025 (GLOBE NEWSWIRE) — Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that Sev Melkonian has joined the company as Vice President of Patient Services, Distribution, and Reimbursement. Mr. Melkonian has extensive industry experience building and leading healthcare operations and patient […]

(NYSE:TRU), NEW ORLEANS, Jan. 22, 2025 (GLOBE NEWSWIRE) — Over the coming year, many consumers considering an auto loan or lease may be reentering the market with far more complicated credit pictures than they did, even just a few years ago. The findings come from a new analysis released today by TransUnion (NYSE: TRU) in

DURHAM, N.C., Jan. 22, 2025 (GLOBE NEWSWIRE) — IMMvention Therapeutix, Inc., an early-stage biotechnology company focused on discovering and developing human therapeutics, today announced a strategic collaboration and license agreement with Novo Nordisk A/S to co-develop oral therapies for sickle cell disease (SCD) and other chronic conditions. The partnership will leverage IMMvention's investigational small-molecule BACH1

(NASDAQ:BLBX), DALLAS, Jan. 22, 2025 (GLOBE NEWSWIRE) — Blackboxstocks Inc. (NASDAQ: BLBX), (“Blackbox” or the “Company”), a financial technology and social media hybrid platform offering real-time proprietary analytics for stock and options traders, announced today that on January 17, 2025 the Company entered into a Securities Purchase Agreement (the “Purchase Agreement”) pursuant to which the

(NasdaqGM:PUBM), NO-HEADQUARTERS/REDWOOD CITY, Calif., Jan. 22, 2025 (GLOBE NEWSWIRE) — TCL, a leading global television brand and PubMatic (Nasdaq: PUBM), an independent technology company delivering digital advertising's supply chain of the future, today announced a new partnership designed to enhance programmatic advertising for live sports. This new partnership will connect TCL's premium programmatic streaming inventory,

SAN FRANCISCO, Jan. 22, 2025 (GLOBE NEWSWIRE) — Cribl, the Data Engine for IT and Security, today announced it has surpassed $200 million in annual recurring revenue (ARR), growing ARR by more than 70 percent year-over-year (YoY). This follows the company's achievement of $100 million in ARR in October 2023, when it became the fourth

(CNSX:DMED.CN),(OTC US:DGNMF),(Other OTC:DGNMF), TORONTO, Jan. 22, 2025 (GLOBE NEWSWIRE) — DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED) (OTCQB: DGNMF), a leading provider of innovative technology solutions for the cleantech and life sciences industries, is proud to announce a strategic collaboration with TerraVent Environmental Inc. (“TerraVent”). This partnership will advance the evaluation and integration

(AUST:RCE.AX),(Frankfurt:R9Q.F), Preliminary data indicates patients experienced either a complete cure or significant improvement in infection symptoms following treatment with R327G Full data analysis expected in Q1 2025 Additional Australian regulatory trials to be initiated in H1 2025 SYDNEY, Jan. 22, 2025 (GLOBE NEWSWIRE) — Recce Pharmaceuticals Ltd (ASX: RCE, FSE: R9Q), (Recce or the Company),

VALENCIA, Calif., Jan. 22, 2025 (GLOBE NEWSWIRE) — Nusano, a physics company transforming the production of radioisotopes, and Caspian Studios, an award-winning content-as-a-service studio, today announced the launch of the Talk Radioisotopes podcast. Presented by Nusano, Talk Radioisotopes is an educational program dedicated to showcasing and explaining how radioisotopes are enabling innovative clinical approaches and

(TSX:YRB), MONTRÉAL, Jan. 22, 2025 (GLOBE NEWSWIRE) — Yorbeau Resources Inc. (TSX: YRB), (“Yorbeau” or the “Company”) has commenced the first phase of its 2025 exploration program in the Selbaie Mine area. This first phase consists of approximately 6,000 metres of drilling on the Beschefer property located 9 km southeast of the former Selbaie producer